Spiramycin I

Spiramycin I is a macrolide antibiotic and antiparasitic[1].

Product Specifications

CAS Number

[24916-50-5]

UNSPSC

12352005

Hazard Statement

H302, H312, H332

Target

Antibiotic; Bacterial; Parasite

Type

Natural Products

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/spiramycin-i.html

Purity

91.52

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=CC[C@@H](C[C@H]([C@H](/C=C/C=C/C[C@H](OC(C[C@H]([C@@H]1OC)O)=O)C)O[C@@H]2O[C@@H]([C@H](CC2)N(C)C)C)C)[C@@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C)O[C@H]4C[C@@](O)([C@H]([C@@H](O4)C)O)C)N(C)C)O

Molecular Formula

C43H74N2O14

Molecular Weight

843.05

Precautions

H302, H312, H332

References & Citations

[1]Zhu P, et al. Hydroxylation and hydrolysis: two main metabolic ways of spiramycin I in anaerobic digestion. Bioresour Technol. 2014 Feb;153:95-100.|[2]Klich K, et al., Synthesis, Antibacterial, and Anticancer Evaluation of Novel Spiramycin-Like Conjugates Containing C (5) Triazole Arm. J Med Chem. 2016 Sep 8;59 (17) :7963-73.